Hormonal and genetic control of testicular descent

Reproductive BioMedicine Online

Volumn 15, Issue 6, 2007, Pages 659-665

  Ferlin, Alberto ^a   Zuccarello, Daniela ^a   Garolla, Andrea ^a   Selice, Riccardo ^a   Foresta, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Androgen receptor; Cryptorchidism; INSL3; RXFP2; Testicular descent; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ENDOCRINE DISRUPTOR; GONADORELIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; SOMATOMEDIN; SOMATOMEDIN RECEPTOR; TESTOSTERONE;

CONFERENCE PAPER; CRYPTORCHISM; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HORMONAL REGULATION; HORMONE ACTION; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INCIDENCE; LEYDIG CELL; MALE INFERTILITY; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; RISK ASSESSMENT; SCROTUM; TESTIS CANCER; TESTIS DEVELOPMENT;

EID: 37349126637     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60532-9     Document Type: Conference Paper

References (92)

1. Adham IM, Agoulnik AI 2004 Insulin-like 3 signalling in testicular descent. International Journal of Andrology 27, 257-265.
2. Adham IM, Steding G, Thamm T et al. 2002 The overexpression of the ins13 in female mice causes descent of the ovaries. Molecular Endocrinology 16, 244-252.
3. Adham IM, Emmen JM, Engel W 2000 The role of the testicular factor INSL3 in establishing the gonadal position. Molecular and Cellular Endocrinology 160, 11-16.
4. Adham IM, Burkhardt E, Benahmed M et al. 1993 Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. Journal of Biological Chemistry 268, 26668-26672.
5. Aschim EL, Nordenskjold A, Giwercman A et al. 2004 Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. Journal of Clinical Endocrinology and Metabolism 89, 5105-5109.
6. Baker LA, Nef S, Nguyen MT et al. 2002 The insulin-3 gene: lack of a genetic basis for human cryptorchidism. Journal of Urology 167, 2534-2537.
7. Balvers M, Spiess AN, Domagalski R et al. 1998 Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 139, 2960-2970.
8. Barthold JS, Gonzalez R 2003 The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. Journal of Urology 170, 2396-2401.
9. Bartlett JE, Lee SM, Mishina Y et al. 2002 Gubemacular development in Mullerian inhibiting substance receptor-deficient mice. British Journal of Urology International 89, 113-118.
10. Bay K, Matthiesson KL, McLachlan RI et al. 2006 The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. Journal of Clinical Endocrinology and Metabolism 91, 1108-1111.
11. Bay K, Hartung S, Ivell R et al. 2005 Insulin-like factor 3 serum levels in 135 normal men and 95 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. Journal of Clinical Endocrinology and Metabolism 90, 3410-3418.
12. Bertini V, Bertelloni S, Valetto A et al. 2004 Homeobox HOXA10 gene analysis in cryptorchidism. Journal of Pediatric Endocrinology and Metabolism 17, 41-45.
13. Bochmer AL, Brinkmann O, Bruggenwirth H et al. 2001 Genotype versus phenotype in families with androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 86, 4151-4160.
14. Bogatcheva NV, Ferlin A, Feng S et al. 2007 T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. American Journal of Physiology Endocrinology and Metabolism 292, E138-144.
15. Bogatcheva NV, Truong A, Feng S et al. 2003 GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Molecular Endocrinology 17, 2639-2646.
16. Boisen KA, Kaleva M, Main KM et al. 2004 Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363, 1264-1269.
17. Boockfor FR, Fullbright G, Bullesbach EE et al. 2001 Relaxin-like factor (RLF) serum concentrations and gubernaculum RLF receptor display in relation to pre- and neonatal development of rats. Reproduction 122, 899-906.
18. Brinkmann AO 2001 Molecular basis of androgen insensitivity. Molecular and Cellular Endocrinology 179, 105-109.
19. Buyse M, Feingold M 1979 Syndromes associated with abnormal external genitalia. In: Vallet HL, Porter IH (eds) Genetic Mechanisms of Sexual Development. Academic Press, New York, 425-435.
20. Canto P, Escudero I, Soderlund D et al. 2003 A novel mutation of the insulin-like 3 gene in patients with cryptorchidism. Journal of Human Genetics 48, 86-90.
21. Chamberlain NL, Driver ED, Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22, 3181-3186.
22. Chariton HM, Halpin DM, Iddon C et al. 1983 The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse. Endocrinology 113, 535-544.
23. Chilvers C, Pike MC, Forman D et al. 1984 Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet 2, 330-332.
24. Choong CS, Kemppainen JA, Zhou ZX et al. 1996 Reduced androgen receptor gene expression with first exon CAG repeat expansion. Molecular Endocrinology 10, 1527-1535.
25. El Houate B, Rouba H, Sibai H et al. 2007 Novel mutations involving the INSL3 gene associated with cryptorchidism. Journal of Urology 177, 1947-1951.
26. Emmen JM, McLuskey A, Adham IM et al. 2000a Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen. Endocrinology 141, 4720-4727.
27. Emmen JM, McLuskey A, Adham IM et al. 2000b Involvement of insulin-like factor 3 (Ins13) in diethylstilbestrol-induced cryptorchidism. Endocrinology 141, 846-849.
28. Feng S, Bogatcheva NV, Truong A et al. 2006 Over expression of insulin-like 3 does not prevent cryptorchidism in GNRHR or HOXA 10 deficient mice. Journal of Urology 176, 399-404.
29. Feng S, Cortessis VK, Hwang A et al. 2004 Mutation analysis of INSL3 and GREAT/LGR8 genes in familial cryptorchidism. Urology 64, 1032-1036.
30. Ferlin A, Arredi B, Zuccarello D et al. 2006a Paracrine and endocrine roles of insulin-like factor 3. Journal of Endocrinological Investigations 29, 657-664.
31. Ferlin A, Garolla A, Rigon F et al. 2006b Changes in serum insulin-like factor 3 during normal male puberty. Journal of Clinical Endocrinology and Metabolism 91, 3426-3431.
32. Ferlin A, Bogatcheva NV, Gianesello L et al. 2006c Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Molecular Human Reproduction 12, 401-406.
33. Ferlin A, Vinanzi C, Garolla A et al. 2006d Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clinical Endocrinology 65, 606-610.
34. Ferlin A, Garolla A, Bettella A et al. 2005 Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism. European Journal of Endocrinology 152, 419-425.
35. Ferlin A, Simonato M, Bartoloni L et al. 2003 The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism. Journal of Clinical Endocrinology and Metabolism 88, 4273-4279.
36. Foresta C, Ferlin A 2004 Role of INSL3 and LGR8 in cryptorchidism and testicular functions. Reproductive BioMedicine Online 9, 294-298.
37. Foresta C, Bettella A, Vinanzi C et al. 2004 A novel circulating hormone of testis origin in humans. Journal of Clinical Endocrinology and Metabolism 89, 5952-5958.
38. Foresta C, Ferlin A, Garolla A et al. 1996 Functional and cytologic features of the contralateral testis in cryptorchidism. Fertility and Sterility 66, 624-629.
39. Galan JJ, Guarducci E, Nuti F et al. 2007 Molecular analysis of estrogen receptor alpha gene AGATA haplotype and SNP12 in European populations: potential protective effect for cryptorchidism and lack of association with male infertility. Human Reproduction 22, 444-449.
40. Giwercman A, von der Maase H, Skakkebaek NE 1993 Epidemiological and clinical aspects of carcinoma in situ of the testis. European Urology 23, 104-110;
41. Gorlov IP, Kamat A, Bogatcheva NV et al. 2002 Mutations of the GREAT gene cause cryptorchidism. Human Molecular Genetics 11, 2309-2318.
42. John Radcliffe Hospital Cryptorebidism Study Group 1992 Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. Archives of Disease in Childhood 67, 892-899.
43. John Radcliffe Hospital Cryptorchidism Study Group 1986 Cryptorchidism: an apparent substantial increase since 1960. British Medical Journal 293, 1401-1404.
44. Hsu SY, Nakabayashi K, Nishi S et al. 2002 Activation of orphan receptors by the hormone relaxin. Science 295, 671-674.
45. Huhtaniemi I, Alevizaki M 2006 Gonadotrophin resistance. Best practice and research. Clinical Endocrinology and Metabolism 20, 561-576.
46. Hutson JM, Hasthorpe, S 2005 Abnormalities of testicular descent. Cell and Tissue Research 322, 155-158.
47. Hutson JM, Hasthorpe S, Heyns CF 1997 Anatomical and functional aspects of testicular descent and cryptorchidism. Endocrine Reviews 18, 259-280.
48. Ivell R, Bathgate RA 2002 Reproductive biology of the relaxin-like factor (RLF/INSL3). Biology of Reproduction 67, 699-705.
49. Josso N, di Clemente N, Gouedard L 2001 Anti-Mullerian hormone and its receptors. Molecular and Cellular Endocrinology 179, 25-32.
50. Kaleva M, Toppari J 2003 Genetics and hormones in testicular descent. Hormones 2, 211-216.
51. Kolon TF, Wiener JS, Lewitton M et al. 1999 Analysis of homeobox gene HOXA10 mutations in cryptorchidism. Journal of Urology 161, 275-280.
52. Koskimies P, Levallet J, Sipila P et al. 2002 Murine relaxin-like factor promoter: functional characterization and regulation by transcription factors steroidogenic factor 1 and DAX-1. Endocrinology 143, 909-919.
53. Koskimies P, Virtanen H, Lindstrom M et al. 2000 A common polymorphism in the human relaxin-like factor (RLF) gene: no relationship with cryptorchidism. Pediatric Research 47, 538-541.
54. Krausz C, Quintana-Murci L, Fellous M et al. 2000 Absence of mutations involving the INSL3 gene in human idiopathic cryptorchidism. Molecular Human Reproduction 6, 298-302.
55. Kubota Y, Temelcos C, Bathgate RA et al. 2002 The role of insulin 3, testosterone, Mullerian inhibiting substance and relaxin in rat gubernacular growth. Molecular Human Reproduction 8, 900-905.
56. Kubota Y, Nef S, Farmer PJ et al. 2001 Leydig insulin-like hormone, gubernacular development and testicular descent. Journal of Urology 165, 1673-1675.
57. Kumagai J, Hsu SY, Matsumi H et al. 2002 INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. Journal of Biological Chemistry 277, 31283-31286.
58. Lim HN, Raipert-de Meyts E, Skakkebaek NE et al. 2001a Genetic analysis of the INSL3 gene in patients with maldescent of the testis. European Journal of Endocrinology 144, 129-137.
59. Lim HN, Nixon RM, Chen H et al. 2001b Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. Journal of Clinical Endocrinology and Metabolism 86, 3207-3210.
60. Lovell-Badge R, Canning C, Sekido R 2002 Sex-determining genes in mice: building pathways. Novartis Foundation Symposium 244, 4-18.
61. Marin P, Ferlin A, Moro E et al. 2001a Different insulin-like 3 (INSL3) gene mutations not associated with human cryptorchidism. Journal of Endocrinological Investigations 24, RC13-15.
62. Marin P, Ferlin A, Moro E et al. 2001b Novel insulin-like 3 (INSL3) gene mutation associated with human cryptorchidism. American Journal of Medical Genetics 103, 348-349.
63. Nef S, Parada LF 2000 Hormones in male sexual development. Genes and Development 14, 3075-3086.
64. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Ins13. Nature Genetics 22, 295-299.
65. Nef S, Shipman T, Parada LF 2000 A molecular basis for estrogen-induced cryptorchidism. Developmental Biology 224, 354-361.
66. Nguyen MT, Showalter PR, Timmons CF et al. 2002 Effects of orchiopexy on congenitally cryptorchid insulin-3 knockout mice. Journal of Urology 168, 1779-1783;
67. O'Shaughnessy PJ, Willerton L, Baker PJ 2002 Changes in Leydig cell gene expression during development in the mouse. Biology of Reproduction 66, 966-975.
68. Overbeek PA, Gorlov IP, Sutherland RW et al. 2001 A transgenic insertion causing cryptorchidism in mice. Genesis 30, 26-35.
69. Pitteloud N, Hayes FJ, Boepple PA et al. 2002 The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 87, 152-160.
70. Radpour R, Rezaee M, Tavasoly A et al. 2007 Association of long polyglycine tracts (GGN repeats) in exon 1 of the androgen receptor gene with cryptorchidism and penile hypospadias in Iranian patients. Journal of Andrology 28, 164-169.
71. Roh J, Virtanen H, Kumagai J et al. 2003 Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism. Reproductive BioMedicine Online 7, 400-406.
72. Sasagawa I, Suzuki Y, Tateno, T et al. 2000 CAG repeat length of the androgen receptor gene in Japanese males with cryptorchidism. Molecular Human Reproduction 6, 973-975.
73. Shen JR, Ingraham HA 2002 Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. Molecular Endocrinology 16, 529-540.
74. Silva-Ramos M, Oliveira JM, Cabeda JM et al. 2006 The CAG repeat within the androgen receptor gene and its relationship to cryptorchidism. International Brazilian Journal of Urology 32, 330-334;
75. Smith KJ, Wade JD, Claasz AA et al. 2001 Chemical synthesis and biological activity of rat INSL3. Journal of Peptide Science 7, 495-501.
76. Spiess AN, Balvers M, Tena-Sempere M et al. 1999 Structure and expression of the rat relaxin-like factor (RLF) gene. Molecular Reproduction and Development 54, 319-325.
77. Sriraman V, Anbalagan M, Rao AJ 2005 Hormonal regulation of Leydig cell proliferation and differentiation in rodent testis: a dynamic interplay between gonadotrophins and testicular factors. Reproductive BioMedicine Online 11, 507-518.
78. Sultan C, Paris F, Terouanne B et al. 2001 Disorders linked to insufficient androgen action in male children. Human Reproduction Update 7, 314-322.
79. Suzuki Y, Sasagawa I, Ashida J et al. 2001 Screening for mutations of the androgen receptor gene in patients with isolated cryptorchidism. Fertility and Sterility 76, 834-836.
80. Takahashi I, Takahashi T, Komatsu M et al. 2001 Ala/Thr60 variant of the Leydig insulin-like hormone is not associated with cryptorchidism in the Japanese population. Pediatrics International 43, 256-258.
81. Terada. M, Goh DW, Farmer PJ et al. 1994 Calcitonin gene-related peptide receptors in the gubernaculum of normal rat and 2 models of cryptorchidism. Journal of Urology 152, 759-762.
82. Tomboc M, Lee PA, Mitwally MF et al. 2000 Insulin-like 3/ relaxin-like factor gene mutations are associated with cryptorchidism. Journal of Clinical Endocrinology and Metabolism 85, 4013-4018.
83. Toppari J, Virtanen H, Skakkebaek NE et al. 2006 Environmental effects on hormonal regulation of testicular descent. Journal of Steroid Biochemistry and Molecular Biology 102, 184-186.
84. Werdelin L, Nilsonne A 1999 The evolution of the scrotum and testicular descent in mammals: a phylogenetic view. Journal of Theoretical Biology 196, 61-72.
85. Wiener JS, Marcelli M, Gonzales ET Jr et al. 1998 Androgen receptor gene alterations are not associated with isolated cryptorchidism. Journal of Urology 160, 863-865.
86. Yamazawa K, Wada Y, Sasagawa I et al. 2007 Mutation and polymorphism analyses of INSL3 and LGR8/GREAT in 62 Japanese patients with cryptorchidism. Hormone Research 67, 73-76.
87. Yoshida R, Fukami M, Sasagawa I et al. 2005 Association of cryptorchidism with a specific haplotype of the estrogen receptor alpha gene: implication for the susceptibility to estrogenic environmental endocrine disruptors. Journal of Clinical Endocrinology and Metabolism 90, 4716-4721.
88. Zhang FP, Poutanen M, Wilbertz J et al. 2001 Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Molecular Endocrinology 15, 172-183.
89. Zimmermann S, Steding G, Emmen JM et al. 1999 Targeted disruption of the Ins13 gene causes bilateral cryptorchidism. Molecular Endocrinology 13, 681-691.
90. Zimmermann S, Schwarzler A, Buth S et al. 1998 Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor- 1. Molecular Endocrinology 12, 706-713.
91. Zimmermann S, Schottler P, Engel W et al. 1997 Mouse Leydig insulin-like (Ley I-L) gene: structure and expression during testis and ovary development. Molecular Reproduction and Development 47, 30-38.
92. Zuccarello D, Morini E, Douzgou S et al. 2004 Preliminary data suggest that mutations in the CgRP pathway are not involved in human sporadic cryptorchidism. Journal of Endocrinological Investigations 27, 760-764.